BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• BioMidwest

  Medtronic Release: Study Shows Prestige LPCervical Disc Patients Maintained Improved Clinical Outcomes And Patient Satisfaction Compared To Fusion At Seven Years

  October 15, 2015

   · 

  3 min read
• International Society for Cellular Therapy Launches The First Guide On Unproven Cellular Therapy For Patients And Community

  October 15, 2015

   · 

  8 min read
• Business

  Queen’s University Belfast And Ulster University Team Up With SynbiCITE To Deliver A ‘Launch Pad’ For Technology Start-Ups

  October 15, 2015

   · 

  4 min read
• Drug Development

  ArQule, Inc. Announces Publication Of Manuscript Highlighting Activity Of AKT Inhibitor ARQ 092 And Next Generation AKT Inhibitor ARQ 751 In Oncology

  October 15, 2015

   · 

  4 min read
• Drug Development

  Prothena To Initiate PRONTO, A Global Trial Of NEOD001 In Patients With AL Amyloidosis With Primary Endpoint Of Cardiac Response

  October 15, 2015

   · 

  8 min read
• Business

  GenoSpace Partner Sequence Bio Announces Initiative With Government Of Newfoundland And Labrador On Large-Scale Precision Medicine Initiative

  October 15, 2015

   · 

  3 min read
• Helsinn’s AKYNZEO (netupitant/palonosetron) Nominated Within The Category “Best Pharmaceutical Agent Of The Year” At The Galien Foundation Prix Awards, New York

  October 15, 2015

   · 

  5 min read
• Drug Development

  Kuros Biosurgery AG To Present Positive kur-115 Pre Clinical Data For Interbody Spinal Fusion Treatment At The 2015 North American Spine Society

  October 15, 2015

   · 

  4 min read
• Business

  Emisphere, Novo Nordisk A/S Ink $221 Million+ Deal Develop Oral Formulations of Four Molecules Targeting Metabolic Indications

  October 15, 2015

   · 

  6 min read
• Business

  GenMark Diagnostics Schedules Third Quarter 2015 Financial Results Conference Call For October 27, 2015

  October 15, 2015

   · 

  1 min read